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Abstract The aim of this study was to investigate the pres-
ence and concentrations of procalcitonin and C-reactive pro-
tein in pericardial fluid and compare these levels to those
found in the postmortem serum obtained from the femoral
blood. Two groups were formed, a sepsis-related fatalities
group and a control group. Postmortem native CT scans,
autopsies, histology, neuropathology and toxicology as well
as other postmortem biochemistry investigations were per-
formed in all cases. Pericardial fluid procalcitonin levels were
significantly different between the cases of sepsis-related
fatalities and those of the control group. Postmortem serum
procalcitonin levels below the detection limit were also
reflected in undetectable pericardial fluid levels. Similarly, a
large increase in postmortem serum procalcitonin levels was
reflected in a large increase of procalcitonin pericardial fluid
levels. Based on these findings, pericardial fluid could be an
alternative to postmortem serum for the determination of
procalcitonin levels in cases where postmortem serum is not
available and measurements of procalcitonin are required to
circumstantiate the pathogenesis of death.
Keywords Procalcitonin . C-reactive protein . Sepsis .
Inflammation . Postmortem biochemistry
Introduction
In clinical practice, procalcitonin and C-reactive protein
(CRP) levels have been investigated, either individually or
in conjunction with other cytokines, to distinguish sepsis
from severe, systemic, non-infectious inflammations [1–8].
Procalcitonin has been indicated as the best marker of
infection in critically ill patients admitted to intensive care
units, whereas measurements of CRP and other cytokines,
such as interleukin-6, have been shown to be non-optimal
in discriminating patients with infections from those with
non-infectious diseases or systemic inflammatory response
syndrome [2].
In clinical practice, sepsis can be difficult to distinguish from
other non-infectious, systemic, inflammatory responses, espe-
cially in critically ill patients admitted to the hospital with
clinical signs of acute inflammation. Biochemical investiga-
tions may therefore provide useful information in distinguish-
ing between systemic inflammatory response syndrome and
various forms of sepsis [2].
Postmortem diagnosis of sepsis is even more difficult to
achieve, mainly because of the lack of medical records at the
moment of the autopsy as well as the absence of specific
macroscopic and microscopic findings (myocardial ischemia,
pulmonary edema, hypoxic liver damage, mesenteric ische-
mia, gastrointestinal haemorrhages, spleen infarction, kidney
ischemia and brain edema), whichmay be of infectious or non-
infectious origin [3, 9, 10]. Thus, the postmortem usefulness of
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procalcitonin and CRP has been studied to discriminate
between sepsis-related fatalities and systemic inflammatory
response syndrome [9–17]. Procalcitonin concentrations have
been principally measured in the postmortem serum obtained
from femoral blood, vitreous humor and cerebrospinal fluid
[9–11, 17]. CRP levels have been tested in the postmortem
serum from femoral blood [12–16], liver [14], vitreous humor
and cerebrospinal fluid [17].
The results of these investigations confirmed the useful-
ness of postmortem procalcitonin measurements in differen-
tiating sepsis-related fatalities from non-septic underlying
causes of death [9, 11]. Moreover, postmortem investiga-
tions have demonstrated that CRP levels can be used in
forensic diagnosis in a similar manner to their use in clinical
practice [10, 12–16].
Pericardial fluid has been used in forensic practice for
several applications to measure different markers, including
glucose, ketone bodies, calcium, sodium, potassium, magne-
sium, urea nitrogen, creatinine, uric acid, markers of myocar-
dial ischemia and cardiac function, insulin, C-peptide and
serotonin [18–32]. Pericardial fluid levels have been found
to be as reliable as blood levels for some of these parameters,
thus suggesting that this substrate could be used for postmor-
tem analyses when postmortem biochemical investigations
are required to circumstantiate the pathogenesis of death and
sufficient amounts of blood are unavailable.
The aim of this study was to investigate both the presence
and concentrations of procalcitonin and CRP in the pericar-
dial fluid of a group of sepsis-related fatalities and a control
group in order to compare pericardial fluid levels of these
two markers to those found in postmortem femoral blood
serum to detect sepsis-related fatalities. Postmortem native
CT scans, autopsies, histology, neuropathology and toxicol-
ogy as well as other postmortem biochemical investigations
were also performed in all cases.
Materials and methods
Subjects
Two groups of study were formed, a sepsis-related fatalities
group and a control group. The sepsis-related fatalities
group consisted of 12 forensic autopsy cases (eight males,
including one 2-month-old infant and four females). The
mean age was 40.5 years. All subjects were admitted to
the intensive care unit of the local university hospital. Ten
cases had documented clinical diagnoses of sepsis in vivo.
The period of the septic condition was between 24 h and
4 days. Complete forensic autopsies were performed within
a 24-h postmortem period on all the cases of this group.
Postmortem microbiological investigations were carried out
on cardiac blood revealing the presence of Pseudomonas
aeruginosa (two cases), Klebsiella pneumoniae (four cases),
Escherichia coli (two cases) and Streptococcus pneumoniae
(one case). In two cases, microbiology revealed the presence
of multiple Gram-positive and Gram-negative bacteria. In
one case, the postmortem microbiological investigation did
not reveal clearly identifiable pathogens. The cause of death
was attributed to multiple organ failure in all cases.
The control group consisted of 28 forensic autopsy cases (20
males and 8 females, no children among them) with a mean age
of 46 years. As with the group above, the postmortem period
was within 24 h. In three cases, the cause of death was not
determined when the bodies were admitted to the medico-legal
center. For 10 cases, the cause of death was attributed to severe
chest and/or abdominal trauma following traffic accidents with
survival time up to 2 h. The cause of death was attributed to
head injury in another 10 cases, with or without chest and
abdominal trauma, following high falls with a survival time
up to 6 h. In the remaining five cases, the cause of death was
attributed to carbonmonoxide intoxication in bodies presenting
extensive burns of the skin, fat tissue and skeletal muscles. No
individuals in this group had any medical history of infectious
diseases or septic conditions prior to their death. Macroscopic
and microscopic examination did not reveal any findings that
suggested the existence of an underlying infectious disease.
Microbiological investigations were not performed.
Samples collection
Postmortem serum samples
Using a sterile needle and a syringe, postmortem blood sam-
ples were collected by aspiration of the femoral vein during
the autopsy. All blood samples were centrifuged immediately
post-collection at 3,000×g for 15 min. After centrifugation,
the separated supernatant (postmortem serum) was collected,
stored in tubes without preservatives and frozen at −20 °C.
Pericardial fluid samples
Undiluted samples of pericardial fluid were collected imme-
diately after an incision in the pericardium during the au-
topsy. All the samples were immediately centrifuged at
3,000×g for 15 min. After centrifugation, the separated
supernatant was collected, stored in tubes without preserva-
tives and frozen at −20 °C.
Analyses
Determination of procalcitonin concentration
KRYPTOR® (B·R·A·H·M·S, Henningsdorf, Germany) was
used tomeasure the procalcitonin concentration. KRYPTOR®
uses time-resolved amplified cryptate emission technology,
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which is based on a non-radiative transfer of energy. This
transfer occurs between two fluorescent tracers: europium
cryptate (donor) and XL665 (acceptor). The signal measured
during the formation of the antigen–antibody complex is
accompanied by amplification. KRYPTOR® assays are
homogeneous and do not require separation or washing.
The molecules of procalcitonin present in the assay samples
are sandwiched between the antibodies. The intensity of the
signal is proportional to the amount of procalcitonin present.
The shape of the standard curve is identical to that obtained
using immunometric methods. The results are expressed in
micrograms per liter.
Determination of C-reactive protein concentration
SYNCHRON® C-reactive protein reagent (Beckman Coulter,
Inc., Brea, USA) was used to measure the CRP concentrations
using the turbidimetric method specified in the supplier's
instructions. In this reaction, the CRP combines with specific
antibodies to form insoluble antigen–antibody complexes. The
SYNCHRON® system automatically proportions the appro-
priate volumes of the sample and the reagent into a cuvette at
the ratio of 1 part sample to 26 parts reagent. The system
monitors the change in absorbance at 340 nm. This change in
absorbance is proportional to the concentration of CRP in the
sample and is used by the system to calculate and express the
CRP concentration, based upon a multi-point, non-linear cal-
ibration curve. The results are expressed in milligrams per liter.
Statistical method
A sensitivity analysis was carried out in order to examine
whether or not postmortem serum procalcitonin and CRP
concentrations correlated to pericardial fluid values. Accord-
ing to the laboratory references, procalcitonin values were
dichotomized into “non-septic values” (concentrations lower
than 2 μg/l) and “septic values” (concentrations greater than
2 μg/l) and CRP values into “normal values” (concentrations
lower than 10 mg/l) and “increased values” (concentrations
greater than 10 mg/l). Pearson's correlation coefficient was
used to assess the correlation between postmortem serum and
pericardial fluid levels for procalcitonin and CRP.
Results
Results are reported in Table 1. The analysis of both pro-
calcitonin and CRP markers in the septic group revealed that
the diagnostic performance of the former was better than the
latter, with a sensitivity of 91.67 %.
Increased postmortem serum procalcitonin levels were
noted in all cases of sepsis. Such increases were furthermore
accompanied by increases in CRP levels in 11 out of 12
cases. The only CRP-negative case in the sepsis group was
the 2-month-old infant (case 1, Table 1). Increased postmor-
tem serum CRP levels without parallel postmortem serum
procalcitonin increases were detected in six of the control
cases presenting head injuries, with or without chest and
abdominal trauma, having a survival time up to 6 h.
Considering that normal and pathological procalcitonin
blood levels in living people show similar ranges in both
postmortem serum and pericardial fluid (concentrations
greater than 2 μg/l for septic states), postmortem serum
procalcitonin levels below the detection limit (<0.06 μg/l)
in 25 control cases were reflected in undetectable pericardial
fluid levels in the same 25 control cases.
Table 1 Septic cases included
in the study
Cases 13, 14 and 15 are control
cases showing increased procal-
citonin levels in both postmor-
tem serum and pericardial fluid.
Explanations indicated in text.
Procalcitonin results are
expressed in micrograms per
liter. CRP results are expressed
in milligrams per
liter
S postmortem serum from
femoral blood, PF pericardial
fluid, M male, F female,
N.I. not clearly identifiable
pathogens, N.P. not performed
Case Microbiology Procalcitonin S Procalcitonin PF CRP S CRP PF
1, M (infant) K. pneumoniae 47.13 41.57 3 3
2, M E. coli 3.77 6.06 58 31
3, M P. aeruginosa 9.26 5.52 19 7
4, M K. pneumoniae 16.58 27.73 25 7
5, M P. aeruginosa 85.50 131.01 285 87
6, M multiple bacteria 5.20 7.55 44 52
7, M N.I. 6.04 1.46 56 20
8, M E. coli 8.87 10.31 130 48
9, F K. pneumoniae 27.75 8.68 150 37
10, F S. pneumoniae 3.68 5.40 171 41
11, F K. pneumoniae 24.58 16.37 90 19
12, F Multiple bacteria 4.02 5.51 161 52
13, M N.P. 1.62 5.31 65 98
14, F N.P. 1.76 2.33 61 60
15, M N.P. 0.41 2.73 53 29
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Measurements of procalcitonin in the pericardial fluid
appear to be a possible alternative to postmortem serum,
with a sensitivity of 90 % and a specificity of 89.29 %.
Pearson's correlation coefficient was 0.947 and 0.751 for
procalcitonin and CRP, respectively. The analysis of pro-
calcitonin in pericardial fluid revealed one false-negative
in the group of sepsis-related fatalities (case 7, Table 1)
and three false-positive cases in the control group (cases 13–15,
Table 1).
The pericardial fluid procalcitonin concentration of the
only false-negative case in the sepsis group was consistent
with what would be expected in a generalised bacterial infec-
tion (1.46 μg/l), whereas the three false-positive cases in the
control group had procalcitonin pericardial fluid levels con-
sistent with a state of sepsis (5.31, 2.33 and 2.73 μg/l) though
postmortem serum levels did not confirm this diagnosis.
However, in two cases, procalcitonin postmortem serum con-
centrations were consistent with generalised bacterial infec-
tions (1.76 and 1.62 μg/l).
Measurements of CRP in the pericardial fluid revealed
two false-negatives in the sepsis group (cases 3 and 4,
Table 1), two false-positives in the control group and one
false-positive in the control group, with 80.00 % sensitivity
and 95.00 % specificity. The pericardial fluid CRP concen-
trations in the false-positive and false-negative cases were
more difficult to compare to corresponding postmortem
serum concentrations.
Discussion
The aim of this study was to investigate the usefulness of
measuring procalcitonin and CRP concentration in pericar-
dial fluid for the postmortem diagnosis of sepsis. Concen-
trations of both these markers were compared in postmortem
serum and pericardial fluid in a group of sepsis-related
fatalities as well as a control group.
The results of our study indicate that pericardial fluid
could be considered an alternative to postmortem serum in
cases in which procalcitonin measurement is required and
postmortem serum is unavailable. Indeed, postmortem
serum procalcitonin levels below the detection level in control
cases were also undetectable in the pericardial fluid. Similarly,
a marked increase of procalcitonin levels in the postmortem
serum of septic cases was reflected in increased pericardial
fluid levels.
Procalcitonin is not the only biochemical marker which
has been associated, in clinical and medico-legal investiga-
tions, with various sepsis-related outcomes. CRP and other
cytokines, such as interleukin-6 and interleukin 8, have also
been postulated as being potentially useful in the diagnosis
of bacterial sepsis. However, more recent studies have
somewhat put into question the diagnostic functionality of
CRP in distinguishing sepsis from non-infectious systemic
inflammatory response syndrome. These studies have sug-
gested that increased CRP levels be considered as a non-
specific indicator of an underlying inflammatory process
rather than a specific marker of sepsis.
The results of the study herein presented are consistent
with the findings above and confirm that CRP is not as
discriminating as procalcitonin in the detection of bacterial
sepsis. This leads to the conclusion that the diagnostic
potential of procalcitonin in detecting sepsis-related out-
comes should be opted for over CRP when cases of sudden,
unexpected deaths appear in situations where sepsis can be
listed as a possible cause of or significant contributing
condition to death.
The postmortem diagnosis of sepsis-related fatalities
remains a difficult challenge for forensic pathologists due
to the absence of typical macroscopic and microscopic
morphological findings as well as insufficient, inexistent
or unavailable medical records upon autopsy. Postmortem
biochemical markers can provide useful information in or-
der to support and enforce morphological findings and are
therefore necessary to confirm or exclude this diagnosis.
The conversion of clinical analyses and reference values
to the postmortem field can be relatively arduous for several
reasons. Among these factors are biochemical marker sta-
bility in the biological fluids after death, postmortem
changes, postmortem haemolysis and often the unavailabil-
ity of qualitatively acceptable biological samples.
Thus, it is extremely important to investigate the relation-
ship between clinical and postmortem biochemical analyses
to test result reliability as well as the applicability of clinical
reference values in the postmortem period. It is, however,
also important to dispose of alternative biological fluids to
analyse for postmortem biochemical investigations. This is
especially relevant in forensic practice, where it is not infre-
quent that either peripheral or cardiac blood is unavailable
for analyses and postmortem biochemistry could provide
important information.
Based on these assumptions, we have decided to test the
usefulness of pericardial fluid as a biological substrate for
postmortem biochemical investigations in order to diagnose
sepsis-related fatalities. Pericardial fluid is relatively easy to
obtain during autopsy and small amounts can be collected
even when a body presents advanced postmortem changes.
The composition of normal pericardial fluid has been in-
vestigated by several authors [33–37]. In 2005, Ben-Horin et
al. [37] proposed a detailed analysis of the normal pericardial
fluid obtained from 30 consecutive patients who had been
admitted to the hospital for elective open heart surgery due to
coronary or valvular disease. Biochemical analyses showed
that the concentrations of small molecules, such as urea nitro-
gen, creatinine, uric acid, electrolytes and glucose, corre-
sponded to an ultrafiltrate of plasma. In contrast, lactate
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dehydrogenase (LDH) and protein levels were higher than
expected for large molecules in a plasma ultrafiltrate and were
usually above the exudate cut-off level used by Light's criteria
[38] for the pleural fluid.
Physiological pericardial fluid is believed to be a transu-
date generated by the net result of the hydrostatic pressure
and the osmotic gradient, like other serosal fluids, such as
the pleural and peritoneal fluids. The results of the study
performed by Ben-Horin et al. [37] confirmed the transuda-
tive nature of the pericardial fluid in relation to the small
molecules and the exudative range, as defined for pleural
effusions [38], for LDH and protein content. According to
the authors, the explanation of the high LDH and protein
levels in the physiologic pericardial fluid is uncertain but
can be the consequence of a preferential leak from the
adjacent perimyocardial tissue.
In medico-legal literature, total ketone body and 3-β-
hydroxybutyrate concentrations, as well as insulin, C-
peptide, electrolytes, renal function markers, serotonin and
markers of cardiac function have been studied in the peri-
cardial fluid by several authors [18–32]. Positive correla-
tions between blood and pericardial fluid ketone body levels
have been shown by Pounder [18]. Our own experience
confirmed the conclusions of Pounder, as well as increased
insulin concentration in the pericardial fluid of a case of
insulin overdose [19].
Zhu et al. [21, 22] studied the correlations between urea
nitrogen, creatinine and uric acid levels in the postmortem
serum and pericardial fluid. They emphasised the usefulness
of the comparison between blood and pericardial fluid val-
ues to confirm the existence of persistent metabolic disor-
ders preceding the death and obtain information pertaining
to survival time. Furthermore, measurements of cardiac
biomarkers [24–31] in pericardial fluid have been indicated
as useful in the investigation of myocardial damage severity.
The study herein presented is the first comparison
between procalcitonin and CRP postmortem serum and
pericardial fluid levels. The results of our investigations
suggest that procalcitonin can be reliably measured in
pericardial fluid for forensic purposes when postmortem
serum is unavailable and biochemical investigations are
required to confirm or exclude the diagnosis of sepsis-
related fatalities. Conversely, even if further studies and
investigations are required to confirm these findings, the
data seem to indicate that more caution is necessary
when comparing postmortem serum to pericardial fluid
CRP levels.
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